Savara Pharmaceuticals
SVRA
#6616
Rank
$0.55 B
Marketcap
$3.22
Share price
-1.23%
Change (1 day)
-30.00%
Change (1 year)

Savara Pharmaceuticals (SVRA) - Cash on Hand

Cash on Hand as of September 2024 : $0.21 Billion USD

According to Savara Pharmaceuticals's latest financial reports the company has $0.21 Billion USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Savara Pharmaceuticals - Cash on Hand chart (from 2002 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31$0.16 B28.95%
2022-12-31$0.12 B-21.9%
2021-12-31$0.16 B96.1%
2020-12-31$82.18 M-32.5%
2019-12-31$0.12 B9.86%
2018-12-31$0.11 B17.51%
2017-12-31$94.31 M605.25%
2016-12-31$13.37 M-67.37%
2015-12-31$40.98 M-28.47%
2014-12-31$57.28 M29.05%
2013-12-31$44.39 M21.58%
2012-12-31$36.51 M-27.99%
2011-12-31$50.7 M81.22%
2010-12-31$27.97 M222.81%
2009-12-31$8.66 M-12.01%
2008-12-31$9.84 M-70.56%
2007-12-31$33.46 M-35.33%
2006-12-31$51.74 M129.03%
2005-12-31$22.59 M73.36%
2004-12-31$13.03 M208.35%
2003-12-31$4.22 M3966.66%
2002-12-31$0.1 M-36.81%
2001-12-31$0.16 M-88.92%
2000-12-31$1.48 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
$16.39 M-92.53%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.40 B 85.20%๐Ÿ‡บ๐Ÿ‡ธ USA